The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published its AI Strategy (the Strategy) in ‘Impact of AI on the regulation of medical products’. The paper outlines the MHRA’s intended strategic approach to AI in the field of medicine and science, and the steps it is taking to meet the UK government’s expectations. Here we analyse the Strategy and put it into context, including developments since its release and cross-regulatory and international observations.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Sofia
Contact Sofia, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack